A new method to test for HIV drug resistance in low-resource areas
Simple Method for Screening of HIV Drug Resistance in Resource-Limited Settings
['FUNDING_OTHER'] · DISCIDIUM BIOSCIENCES, LLC · NIH-10384759
This study is working on a new, easy, and affordable test to check for HIV drug resistance, especially for people in low and middle-income countries, so they can get quick results from their blood without needing fancy lab equipment.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DISCIDIUM BIOSCIENCES, LLC (nih funded) |
| Locations | 1 site (MIAMI, UNITED STATES) |
| Trial ID | NIH-10384759 on ClinicalTrials.gov |
What this research studies
This research aims to create a simple and cost-effective test for detecting HIV drug resistance in low and middle-income countries. The approach involves a single tube assay that uses lyophilized reactants and standard PCR techniques, allowing for testing in laboratories with minimal infrastructure. By focusing on common mutations associated with resistance to antiretroviral therapies, the test can provide quick results directly from unprocessed blood samples. This innovative method could significantly improve access to necessary testing in regions where traditional methods are unaffordable.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV in low and middle-income countries who are undergoing antiretroviral therapy.
Not a fit: Patients who are not living with HIV or those in high-income countries with access to standard resistance testing may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a reliable and affordable way for patients in resource-limited settings to be screened for HIV drug resistance, leading to more effective treatment options.
How similar studies have performed: Other research has shown success with similar low-cost testing approaches in resource-limited settings, indicating the potential for this method to be effective.
Where this research is happening
MIAMI, UNITED STATES
- DISCIDIUM BIOSCIENCES, LLC — MIAMI, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STEVENSON, MARIO — DISCIDIUM BIOSCIENCES, LLC
- Study coordinator: STEVENSON, MARIO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.